CENTER ID: | LemaA.00437.c |
ORGANISM: | Leishmania major Friedlin |
ASSOCIATED DISEASE: | Cutaneous leishmaniasis |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
unclassified |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
LemaA.00437.c.B2.GE40687 | disordered N-term truncation | 17 | 355 | ||
LemaA.00437.c.B3.GE40688 | disordered N and C term truncation | 17 | 319 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
LemaA.00437.c.B2.PS38418 | disordered N-term truncation | 17 | 355 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | TriTrypDB:LmjF.18.0270 |
UniProt: | Q4QE15 |
HARVESTED ON: | 11/8/2016 |
SEQUENCED ON: | 11/8/2016 |
EXPECTED MW: | 40kDa |
OBSERVED MW: | 40kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Low Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 97 |
HARVESTED ON: | 11/8/2016 |
SEQUENCED ON: | 11/8/2016 |
EXPECTED MW: | 36kDa |
OBSERVED MW: | 36kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | No Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 97 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 3/6/2018 |
CONCENTRATION: | 21.5mg/ml |
OBSERVED MW: | 42kDa |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | 20 mM HEPES pH 7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 3 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 97 |